4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000027
Chief Medical Officer sold 22,575 shares at an average $28.91 ($652,638)
- Chief Medical Officer acquired 16,226 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-05-11 | Option exercise 10b5-1 | +2,171 | $16.00 | $34,736 | 71,963 | D |
| Rodman David Malcom Chief Medical Officer | 2026-05-11 | Sale 10b5-1 | −2,171 | $29.71 | $64,500 | 69,792 | D |
| Rodman David Malcom Chief Medical Officer | 2026-05-12 | Option exercise 10b5-1 | +6,348 | $1.08 | $6,856 | 76,140 | D |
| Rodman David Malcom Chief Medical Officer | 2026-05-12 | Sale 10b5-1 | −6,348 | $29.36 | $186,348 | 69,792 | D |
| Rodman David Malcom Chief Medical Officer | 2026-05-13 | Option exercise 10b5-1 | +3,541 | $10.20 | $36,118 | 73,333 | D |
| Rodman David Malcom Chief Medical Officer | 2026-05-13 | Option exercise 10b5-1 | +4,166 | $14.25 | $59,366 | 77,499 | D |
| Rodman David Malcom Chief Medical Officer | 2026-05-13 | Sale 10b5-1 | −14,056 | $28.58 | $401,789 | 63,443 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-05-11 | Option exercise · Stock Option 10b5-1 | −2,171 | 19,535 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-05-12 | Option exercise · Stock Option 10b5-1 | −6,348 | 12,698 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-05-13 | Option exercise · Stock Option 10b5-1 | −3,541 | 116,876 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-05-13 | Option exercise · Stock Option 10b5-1 | −4,166 | 87,501 | D | ||
| Open-market sales · 22,575 sh · avg $28.91 · $652,638 | |||||||
Loading xslF345X06/wk-form4_1778722925.xml…